A window of opportunity for cooperativity in the T Cell Receptor by Martin-Blanco, N et al.
ARTICLE
A window of opportunity for cooperativity in the
T Cell Receptor
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The T-cell antigen receptor (TCR) is pre-organised in oligomers, known as nanoclusters.
Nanoclusters could provide a framework for inter-TCR cooperativity upon peptide antigen-
major histocompatibility complex (pMHC) binding. Here we have used soluble pMHC oli-
gomers in search for cooperativity effects along the plasma membrane plane. We ﬁnd that
initial binding events favour subsequent pMHC binding to additional TCRs, during a narrow
temporal window. This behaviour can be explained by a 3-state model of TCR transition from
Resting to Active, to a ﬁnal Inhibited state. By disrupting nanoclusters and hampering the
Active conformation, we show that TCR cooperativity is consistent with TCR nanoclusters
adopting the Active state in a coordinated manner. Preferential binding of pMHC to the
Active TCR at the immunological synapse suggests that there is a transient time frame for
signal ampliﬁcation in the TCR, allowing the T cells to keep track of antigen quantity and
binding time.
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T cells contain low-afﬁnity receptors (T-cell receptors,TCRs) that nonetheless achieve high speciﬁcity and sen-sitivity for antigen peptide/MHC (pMHC) ligands1. This
paradox is exacerbated when considering that the difference in
afﬁnity for pathogen-derived pMHC versus self-pMHC com-
plexes is small enough to be compensated by the law of mass
action. A hypothetical explanation is that TCRs are pre-organised
in nanoclusters of up to 20 TCRs that could provide a framework
for inter-TCR cooperativity upon pMHC binding2–6.
The TCR is composed of six subunits (TCRα, TCRβ, CD3γ,
CD3δ, CD3ε and CD3ζ) without intrinsic enzymatic activity, but
functionally associated to cytoplasmic tyrosine kinases7. Using
monovalent versus multivalent fragments of activating antibodies
and monomeric and multimeric forms of recombinant soluble
pMHC, it was found that simultaneous binding of two or more
TCRs by the ligands is required for TCR triggering8–11. Since the
TCR appears to be organised in nanoclusters before antigen
binding3–6, the need for bivalent or multivalent binding of the
pMHC ligand must not rely on promoting dimerisation
or multimerization, for TCR nanoclusters are already oligomeric.
Instead, we found that ligand-mediated TCR crosslinking is
required to stabilise the TCR in its Active conformation11,
opening the possibility of allosteric regulation within
nanoclusters.
Allostery is intrinsic to the control of metabolic and signal-
transduction pathways. It is deﬁned in functional terms as a
comparison of how a ligand binds in the presence or absence of
an already bound ﬁrst ligand12. Membrane receptors offer
examples of allostery, as is the case of ligand binding to the
ectodomain of seven transmembrane receptors13. Upon binding,
transmission of information across the membrane to the cyto-
plasm favours the binding of a signalling G protein to a distal site.
Furthermore, this information is also transmitted along the plane
of the membrane, resulting in the formation of receptor homo-
dimers or heterodimers that affect binding of a second extra-
cellular ligand14.
In this context, we have now approached the study of pMHC
ligand binding to the TCR in search of homotropic allosteric
effects along the plane of the plasma membrane. We provide
evidence suggesting the existence of cooperativity upon ligand
binding. However, we found that this cooperativity peaks 4–8 min
after TCR engagement by the ﬁrst pMHC ligand and decays
thereafter. This delineates a time window in which signal
ampliﬁcation could operate by favouring additional pMHC ligand
binding to TCRs in the same nanocluster. Considering the
transition of the TCR between three activation states, we propose
a model for regulation of T-cell activation in physiological con-
ditions. By means of mathematical modelling, we show that the
observed effects are consistent with cooperativity among recep-
tors in nanoclusters and the coexistence of three allosteric con-
ﬁgurations with different functional properties.
Results
A time optimum for Active TCR. The monoclonal antibody
APA1/1 detects a conformational epitope in the cytoplasmic tail
of CD3ε (Fig. 1a)15. This epitope lies within the proline-rich
sequence in CD3ε and becomes exposed when the TCR is trig-
gered by binding to an activating ligand. We have studied how
APA1/1 epitope is exposed upon stimulation of CD8+ T cells
from OT-1 TCR transgenic mice with a soluble H-2Kb tetramer
loaded with the strong TCR agonist OVAp (SIINFEKL; OVAp
tetramer from now on). We ﬁrst titrated the concentrations of
OVAp tetramer that are optimal for the activation of OT-1 T cells
24 h after stimulation, measured by the induction of CD69 and
CD25 expression. Expression of both activation markers peaked
at concentrations of 1–10 nM. Higher doses did not improve the
response (Fig. 1b) or even worsened it (Supplementary Fig. 1a).
Interestingly, OVAp tetramer concentrations leading to max-
imum T-cell activation (1–10 nM) was well below that needed for
saturation of binding (above 1000 nM). Titration curves for the
OVAp tetramer were also performed by incubation for a shorter
time at 0 °C, conﬁrming that concentrations higher than 1000 nM
are needed to saturate all binding sites on T cells (Fig. 1c). When
OVAp tetramer binding at a sub-saturating concentration (1 nM)
at 0 °C was plotted as a function of time, we found that maximum
binding was not reached even after 20 min of incubation (Fig. 1d).
However, when the exposure of APA1/1 epitope was plotted, we
found a maximum at 6 min, with a decline afterwards, even
though binding of the OVAp tetramer continued to increase.
Although binding of 1 nM OVAp tetramer had not reached a
plateau after 20 min of incubation, the use of a 200-fold higher
concentration of tetramer (200 nM) accelerated the binding and a
plateau was reached after 8 min of incubation (Fig. 1d). Inter-
estingly, the APA1/1 optimal binding time point was independent
of the concentration of tetramer (1 versus 200 nM) used to induce
the exposure of the APA1/1 epitope. The time maximum was also
unaltered when incubations were carried out at 37 °C, indicating
that the molecular processes leading to the skewed bell-shaped
curve of APA1/1 epitope exposure were largely temperature-
independent and therefore independent of the cell’s metabolism
(Fig. 1e). Control experiments were also carried out to assess TCR
speciﬁcity towards OVAp tetramer binding and tetramer-
triggered exposure of the APA1/1 epitope. OT-1 CD8+ T cells
were stimulated with 1 nM OVAp tetramer, in parallel to sti-
mulation of CD8+ T cells from another mouse line, which bears
a TCR transgene of irrelevant speciﬁcity (HY TCR). Both tetra-
mer binding and time-dependent APA1/1 exposure were speciﬁc
of the OT-1 TCR (Fig. 1f and Supplementary Fig. 1b). In order to
exclude that the binding properties of the OVAp tetramer were
altered by the presence of tetramer aggregates, we analysed
the OVAp-APC tetramer by size-exclusion chromatography. The
MHC-I heavy chain peaked in fractions between 1.5 and 2 ml
(Supplementary Fig. 1c) which presented maximum binding
activity in OT-1 CD8+ T cells (Supplementary Fig. 1d). The
molecular weight of these fractions was between 150 and 669 kDa,
in the range of the expected size for the OVAp-APC tetramer
(~242 kDa tetramer+ ~105 kDa APC= ~347 kDa), not far from
previous gel ﬁltration results16 and contaminating trimers, dimers
and monomers17. No MHC-I heavy chain or binding activity was
detected in fractions < 1 ml, indicating the absence of large
aggregates in the OVAp tetramer preparation (Supplementary
Fig. 1c and 1d).
The data above highlight that there is an optimum time point
for APA1/1 epitope exposure, indicative of Active conformation
of the TCR when CD8+ T cells are stimulated with MHC-I
tetramer concentrations well below saturation.
A 3-state model can explain the time optimum for Active TCR.
In order to get insight into the time-dependent exposure of
APA1/1 epitope, we ﬁrst assumed a 2-state model (Resting and
Active, Fig. 1a and Fig. 2a), in which ligand binding stabilises
the Active state and this effect lasts as long as the pMHC ligand
is bound to the TCR. With this 2-state model, a plateau of TCR
in the Active conformation is reached and does not decrease
(Fig. 2b). However, a 3-state conformational model would suc-
cessfully account for the decreasing behaviour of the curve after
6 min of incubation. Each of the three states corresponds to
ensembles of different allosteric conﬁgurations. The Resting state
is formed by the ensemble of all conformations, in which neither
the extracellular domains of the TCRα/β subunits are in an
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optimal orientation for binding nor are the cytoplasmic CD3 tails
prone to binding effector proteins. The Active state is formed by
the ensemble of conformations optimal for pMHC binding to
TCRα/β in all TCRs, as well as for cytoplasmic effector binding by
CD3 subunits in all TCRs. Lastly, the Inhibited state is formed by
the ensemble of conformations in which some TCRα/β ectodo-
mains in the nanoclusters favour pMHC binding and others
do not, whereas the CD3 cytoplasmic tails are not exposed to
intracellular effectors (Fig. 2a). For the sake of simplicity, we
develop a mathematical model of a nanocluster composed of
three TCRs and a trimeric pMHC ligand, which is in fact the
functional valence of a tetramer (Fig. 2c). A model that includes
larger nanoclusters will only change our results in a quantitative,
but not qualitative way18.
We describe the free-energy landscape of the three conforma-
tional states in the absence and presence of ligand-induced
crosslinking in Supplementary Fig. 2a and a summary of the
transitions between states with and without ligand in Fig. 2c.
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The mathematical model captures the free-energy changes
induced by ligand crosslinking and the transition rates between
each nanocluster state. It assumes that single pMHC-mediated
crosslinking is sufﬁcient to stabilise the Active state of the entire
TCR nanocluster, favouring pMHC binding to all TCRs in the
cluster (Fig. 2d). The model is consistent with the experimental
data generated with APA1/1 (Fig. 1d), showing that the number
of nanoclusters in the Active state displays a time-dependent
maximum (Fig. 2e). The location of this maximum is almost
insensitive to parameter changes, such as ligand concentration,
temperature and free-energy differences between the three states
(Supplementary Fig. 2b and Supplementary Note 1).
We can now enquire the model to decide if the existence of the
maximum in the number of TCR nanoclusters in the Active state
has further immunological consequences. Given the decay of the
Active state (as well as the increase of the Inhibited state) shown
in Fig. 2e, the model predicts that the enhancement in subsequent
binding events is a transient effect. This effect can be explored if
we add the ﬁrst dose of pMHC ligand (preincubation), and at a
ﬁxed later time we add a second. In Fig. 2f, we show that binding
of the second ligand is maximised when the preincubation time is
around 5 min, which is the timescale needed for the Active state
to reach its maximum (Fig. 2e).
Ligand binding cooperativity suggests inter-TCR crosstalk.
Following the predictions of the model, we searched for signs of
cooperativity as revealed by the properties of binding to the
pMHC ligand. Thus, we measured the effect of preincubation of
OT-1 T cells (at 0 °C) with a sub-saturating concentration of
APC-labelled OVAp tetramer (1 nM) on subsequent binding of
the same tetramer, but in a different colour (PE), for a ﬁxed time
of 5 min (Fig. 3a). As expected, binding of the OVAp-APC tet-
ramer used for preincubation steadily increased with its time of
incubation (Fig. 3a, blue diamonds). In sharp contrast, binding of
the second tetramer (OVAp-PE) during the 5 min time window
was enhanced if the cells had been preincubated with the ﬁrst
tetramer, with a maximum at 4–6 min of preincubation (Fig. 3a,
red circles). To better adjust the maximum for positive coop-
erativity upon ligand binding, we carried out a similar experiment
by reducing the incubation period with the second tetramer to 1
min. We found a sharp raise in the binding of the second tetra-
mer upon 4 min of preincubation that slowly decayed from 4 to 6
min of preincubation and decayed faster from 6min onwards
(Supplementary Fig. 3a). These results document the existence of
cooperativity phenomena within the TCRs manifested upon
ligand binding, i.e. binding of the pMHC ligand to a few TCRs
improves the subsequent binding of additional pMHC ligands to
free TCRs, albeit during a narrow time window. The effect could
be reproduced using CD8+ T cells from double TCR transgenic
mice that bear two TCRs (OT-1 and HY) of different antigen
speciﬁcity. Preincubation with OVAp-APC tetramer, speciﬁc for
OT-1, exerted a time-dependent cooperative effect on the binding
of a second HYp-PE tetramer speciﬁc for the HY TCR (Fig. 3b).
A similar effect was observed when the order of tetramer addition
was inverted (Supplementary Fig. 3b). The above results show
that clustered TCRs cooperate in the following sense: a con-
formational change in part of the cluster affects the whole
nanocluster and, subsequently, an increase in the number of
clusters in the Active state enhances ligand binding.
Since pMHC interacts with both the TCR and the coreceptors
(CD8 in CD8+ T cells), we interrogated if the transient positive
cooperativity effect upon ligand binding was mediated by binding
to CD8. We found that blocking CD8 using an anti-CD8
antibody strongly inhibited the intensity of OVAp tetramer
binding, but did not abolish the time-dependent cooperativity
effect (Supplementary Fig. 4a). Likewise, an OVAp tetramer
bearing a point mutation that prevents binding to CD8, but not to
the TCR, was also able to induce the transient cooperativity effect
on binding of a second wild-type OVAp tetramer (Supplementary
Fig. 4b).
Ligand binding cooperativity requires TCR crosslinking. The
pMHC tetramers we used are tetrahedral, with a pMHC–pMHC
distance in the tetramer of ~80 Å; higher than the optimal dis-
tance required for effective binding to the T-cell surface19, 20. To
determine if ligand binding cooperativity was related to the
geometry of the pMHC oligomer, we studied binding of ﬂuor-
escent pMHC oligomers based on a linear dextran frame. In
analogy to the pMHC tetramers, we found that preincubation
with an OVAp-PE dextramer had an impact on the binding of a
second OVAp-APC dextramer in a time-dependent manner
(Supplementary Fig. 5a). These results suggest that the exact
arrangement of the pMHC ligands in the stimulating pMHC
oligomer do not seem to be relevant. However, ligand-mediated
TCR crosslinking was required because preincubation with an
OVAp monomer did not inﬂuence subsequent binding of a tet-
ramer either in a time-dependent fashion (Fig. 4a) or in a
concentration-dependent manner (Fig. 4b). However, pre-
incubation with the OVAp tetramer exerted a time-dependent
cooperative effect on the binding of the OVAp monomer
(Fig. 4c). Likewise, preincubation with the OVAp tetramer for 6
min favoured concentration-dependent binding of the monomer
(Fig. 4d). These data suggest not only that TCR crosslinking is
required to induce cooperative binding of subsequent pMHC
ligands, but also that ligand binding cooperativity takes place by
favouring the exposure of individual pMHC-binding sites on
individual TCRs within nanoclusters in the Active conformation.
Cooperativity requires nanoclusters to adopt the Active state.
Tetramer and dextramer binding experiments were carried out
at 0 °C, which decreases the possibility that the ﬁrst phase of
Fig. 1 Optimum time for Active conformation of the TCR at sub-saturating concentrations of the pMHC ligand. a Cartoon of the Resting and ligand-bound
Active conformations of the TCR. Bivalent or multivalent ligation of two or more TCRs by its pMHC ligand results in an outside-in transmission of a
conformational change detected in the cytoplasmic tails of the CD3 subunits. One of these changes consists in exposing an epitope in the proline-rich
region of CD3ε for mAb APA1/1 binding. b OT-1 CD8+ T cells were incubated at 37 °C with the indicated concentrations of APC-labelled OVAp tetramer
for 24 h. After stimulation, cells were stained with anti-CD69 and analyzed by cytometry. The mean ﬂuorescence intensity (MFI) for CD69 staining is
shown as red circles and that of tetramer binding as blue diamonds. c OT-1 CD8+ T cells were incubated on ice with the indicated concentrations of APC-
labelled OVAp tetramer for 40min. MFI was calculated by ﬂow cytometry. d OT-1 CD8+ T cells were incubated at different times at 0 °C with 1 nM or
200 nM of OVAp-APC tetramer and subsequently ﬁxed, permeabilized and stained with the APA1/1 mAb prior to ﬂow cytometry analysis. MFI for APA1/
1 staining is shown as red circles and that of tetramer binding as blue diamonds. e OT-1 CD8+ T cells were incubated at different times at 37 °C with 1 nM
OVAp-APC tetramer and stained with the APA1/1 mAb as in Fig. 1d. f Histogram overlay for APA1/1 expression in OT-1 and HY CD8+ T cells not
incubated (blue lines) or incubated for 2 min (red line) or 5 min (brown line) with 1 nM OVAp-APC tetramer at 0 °C. All data shown in Fig. 1 represent the
mean ± s.d. of triplicate datasets; *p < 0.05; **p < 0.005; ***p < 0.0005 (two-tail unpaired t-test)
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cooperativity could be due to unexpected aggregation of TCR
nanoclusters induced by preincubation with the ﬁrst tetramer.
This could have increased the valence of the TCR for subsequent
binding events. However, this hypothesis is at odds with the
negative slope of the kinetic curves observed typically after 4–8
min of preincubation. Notwithstanding, we examined the dis-
tribution of the TCR on the surface of OT-1 T cells after incu-
bation with OVAp tetramer at 0 °C and 37 °C. Confocal
microscopy revealed the formation of an aggregated cup structure
in T cells incubated with the tetramer at 37 °C, but not when
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incubated at 0 °C (Supplementary Fig. 6a). We also used immu-
nogold and label-fracture electron microscopy to determine if the
size of the pre-existing TCR nanoclusters was altered upon
incubation with OVAp tetramer. We found that while incubation
at 37 °C induced the formation of large 2-dimensional TCR
clusters of even more than 30 TCRs, incubation at 0 °C did not
alter the size of the pre-existing nanoclusters (Supplementary
Fig. 6b).
We then investigated if the observed cooperativity upon ligand
binding depended on the existence of TCR nanoclusters. Since
TCR nanoclusters require cholesterol5, 21, we ﬁrst analysed the
effect of cholesterol extraction with methyl-β-cyclodextrin
(MβCD) on ligand binding cooperativity. We found that
treatment with MβCD did not alter TCR abundance in the
plasma membrane evaluated by incubation with an anti-TCRβ
antibody (Fig. 5a, left). However, cholesterol depletion completely
abrogated the cooperativity effects of OVAp-APC preincubation
on OVAp-PE binding (Fig. 5a, right) and also dramatically
reduced time-dependent binding of OVAp-APC (Fig. 5a, centre),
suggesting that TCR nanoclusters were required for cooperativity.
We next tested if the transient positive effect upon ligand
binding was associated with the adoption of the Active
conformation. We have previously described a point mutation
(C80G) in the stalk sequence of the extracellular domain of CD3ε
(Fig. 5b) that prevents the outside-in transmission of conforma-
tional changes, which would normally result in the exposure of
the proline-rich sequence in the cytoplasmic tail of CD3ε for Nck
binding22. This mutation abrogates αβ T-cell development in the
thymus. Nevertheless, the expression of a TCR transgene partly
rescues this defect, and nearly normal numbers of mature CD8+
T cells bearing the OT-1 TCR are found in lymphoid organs of
mice homozygous for the CD3ε C80G mutation22. However,
since these cells express lower amounts of TCR than their wild-
type counterparts, we tested the effect of the C80G mutation on
OVAp tetramer ligand binding by gating T-cell populations with
equal TCR expression in WT or C80G mutant OT-1 cells (Fig. 5c,
left). Binding of increasing amounts of OVAp tetramer to the WT
population was normalised to match TCR expression in C80G
T cells (WTnorm) and compared with binding to the total WT
population. It was then evident that the difference in TCR
expression (threefold higher in the WT) did not signiﬁcantly
affect the tetramer binding. However, the C80G mutation
inhibited binding, compared with both the unselected and
selected WT populations (Fig. 5c, right). In addition, the C80G
mutation strongly inhibited the transient enhancement in OVAp-
PE tetramer binding promoted by OVAp-APC tetramer pre-
incubation (Fig. 5d). These results show that the TCR needs to
adopt the Active conformation in order for TCR nanocluster
cooperativity to take place. Importantly, the C80G mutation is in
the ectodomain of CD3ε, whereas the pMHC ligand binding site
is formed by the V regions of TCRα and TCRβ. Therefore,
abrogation of binding cooperativity by the C80G mutation
suggests that a transmission of structural rearrangements from
engaged TCRα/β to non-engaged TCRα/β is mediated by CD3ε
and perhaps other CD3 subunits (Fig. 2d).
Ligand binding changes the orientation of TCRα/β ectodo-
mains. We then searched for evidence that could reﬂect structural
rearrangements within TCR nanoclusters that could be respon-
sible for the observed cooperativity upon ligand binding. For this,
we studied ﬂuorescence resonance energy transfer (FRET)
between PE-labelled and APC-labelled tetramers upon simulta-
neous binding to OT-1 T cells as a function of time. FRET
intensity between both tetramers was compared on one hand with
that of a positive control, i.e. energy transfer between the TCR-
bound tetramer and a labelled anti-CD3ε antibody. On the other
hand, the negative control was set as the energy transfer between
the TCR-bound tetramer and anti-CD27 antibody, which is a
membrane protein not described as a TCR interactor (Fig. 6a,
Supplementary Fig. 7a). Binding of both tetramers followed a
similar time-course (Supplementary Fig. 7b). A set of controls of
the FRET assay is shown in Supplementary Fig. 7c. At the end of
the incubation period (20 min) at 0 °C, FRET intensity between
the two bound tetramers was higher than that of the negative
control and even than that of the positive control (Fig. 6b, left
panel). Higher FRET intensity registered for two bound tetramers
than for the positive control (a tetramer and anti-CD3) is likely
reﬂecting a more favourable orientation for FRET. This is prob-
ably due to the fact that two tetramers bind to the tips of two
TCRα/β ectodomains, whereas the anti-CD3 binds the ectodo-
main of CD3ε in a diagonal outward orientation23, 24. The fact
that there is a considerable FRET signal between two binding
tetramers itself reﬂects the existence of preformed TCR
nanoclusters.
FRET intensity increased with time following tetramer binding,
much like FRET intensities for the positive and negative controls.
However, both FRET intensity and FRET efﬁciency between
tetramers experienced a sudden increase between 5 and 8 min
that was not detected in the controls (Fig. 6b, arrows and
Supplementary Fig. 7b). These data indicate that a qualitative
shift in the proximity or orientation of different TCRs is
produced 5 to 8 min after the ﬁrst pMHC tetramer ligands start
binding.
The shift in tetramer–tetramer FRET intensity suggested a
change in the distance, or in the orientation, of the TCRα/β
heterodimers, since they contain the binding site for pMHC. To
address this hypothesis, we assessed if low sub-saturating
concentrations of OVAp tetramer modiﬁed TCRα–TCRβ FRET
measurements. We used unlabelled OVAp tetramer and ﬂuor-
escent anti-Vα2 and anti-Vβ5 antibodies which recognise the
Fig. 2 TCRs are in transit between three different states of conformations. a Cartoon of the Resting, Active and Inhibited states. Blue and red arrows
suggest a possible movement of the αβ ectodomains. Adoption of the three states is also reﬂected by movements of the cytoplasmic tails of the
CD3 subunits. One of these movements results in exposure of the APA1/1 epitope in CD3ε. b A mathematical model with just two states (Resting and
Active) cannot explain the optimum time point for the Active conformation shown in Fig. 1d, e. Rather, Active conformation reaches a plateau of indeﬁnite
duration. c Summary of reactions included in the model. The letters R, A and I stand for the states Resting, Active and Inhibited. A nanocluster of three
TCRs and a trimeric pMHC ligand were chosen for modelling. The numerical values of the parameters and an explanatory description of the states are
summarised in Methods. The plus symbols stand for either empty or non-crosslinked bound ligand used for conciseness. dModel to explain how ligation of
two or more TCRs by pMHC results in stabilisation of the Active conformation in the entire TCR nanocluster. Adoption of the Active conformation by
unbound TCRs facilitates their binding to additional pMHC ligands. e Numerical integration of the 3-state model after addition of ligand. The right panel
shows the existence of an optimum of the Active conformation (red circles), even though binding has not yet reached saturation. This behaviour reﬂects
the experimental results in Fig. 1d–e. f Prediction of the existence of cooperative effects on pMHC ligand binding derived from the mathematical model.
Preincubation of TCR nanoclusters with free ligand at different times displays an optimum cooperation at the time when the maximal number of TCR
nanoclusters in the Active conformation is found (Figs. 1d, e and 2e)
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05050-6
6 NATURE COMMUNICATIONS |  (2018) 9:2618 | DOI: 10.1038/s41467-018-05050-6 | www.nature.com/naturecommunications
variable regions of the OT-1 TCR. Since the tetramer and the
anti-V region antibodies are likely to compete for binding to the
TCR, the effect of tetramer binding would be measured on nearby
unoccupied TCRα/β heterodimers in the nanocluster, in the sub-
saturating conditions of tetramer employed (Fig. 6c). The anti-
Vα2 probe can act as a FRET donor for anti-Vβ5 probe bound to
the same TCR or bound to a different nearby TCR. For this
reason, we carried out FRET analysis in cells pretreated or not
with MβCD to disrupt nanoclusters. We detected an increase of
FRET efﬁciency with an optimum of 4 min that was not apparent
in T cells pretreated with MβCD (Fig. 6d). Interestingly, FRET
efﬁciency in cells not preincubated with tetramer (0 min, Fig. 6d)
was not affected by MβCD, suggesting that the FRET signal that is
resistant to the disruption of nanoclusters is generated by anti-V
region antibodies binding to TCRα and TCRβ within the same
TCR. Hence, the increase in FRET efﬁciency upon preincubation
with tetramer could be produced by inter-TCR rather than intra-
TCR changes within nanoclusters. To investigate inter-TCR
changes produced by preincubation with tetramer in the absence
of intra-TCR signals, we measured FRET signals using FRET
donor and acceptor anti-Vβ5 antibodies conjugated to different
ﬂuorophores. We detected an increase in FRET efﬁciency with a
maximum of 4 min that was completely abolished if TCR
nanoclusters had been disrupted by MβCD treatment (Fig. 6e).
These results indicate that binding of pMHC tetramer to the TCR
produces changes in the quaternary structure of TCR nanoclus-
ters. In fact, in T cells from double transgenic OT-1xHY mice, we
could detect an increase in FRET intensity between two anti-Vα
antibodies speciﬁc to the two different TCRs (Fig. 6f). The
changes detected with anti-Vα and anti-Vβ antibodies, indicative
of changes in the quaternary structure of the TCR, are coincident
with the changes in the inter-tetramer ligand distance or
orientation (Fig. 6b) and with changes in the cooperativity of
tetramer binding (Fig. 3).
Antigen presentation induces TCR cooperativity. Once we
determined that binding of a soluble pMHC multivalent ligand
transiently favoured subsequent binding events, we next inter-
rogated whether cooperativity upon ligand binding was also
detected in a more physiological setting, namely in response to
pMHC antigens presented by professional antigen-presenting
cells (APCs). To this end, we incubated OT-1 CD8+ T cells with
mature dendritic cells (DCs) loaded with the OVA peptide
antigen. The incubation was carried out at 37 °C to allow T cells
to spread onto the APCs by a process that requires remodelling
of the cytoskeleton25. In the time period studied, TCR down-
regulation did not take place (Fig. 7a, left). However, we detected
a clear cooperativity: preincubation with antigen-loaded DCs
for 3–4 min improved binding of a soluble OVAp-PE tetramer,
while longer incubations impaired it (Fig. 7a, centre). To avoid
possible effects due to activation of intracellular signalling path-
ways by engaged TCRs, we pretreated OT-1 T cells with the Src
tyrosine kinase inhibitor PP2 that is known to abrogate TCR
signalling26. Although the intensity of tetramer binding to OT-1
cells treated with PP2 was reduced, the optimum time point of
cooperative binding was similar (Fig. 7a, right). These results
suggest that transient cooperative effects manifested upon ligand
binding are also produced during the physiological activation
of T cells.
Fig. 3 Binding of a ﬁrst pMHC tetramer ligand at sub-saturating
concentrations transiently favours binding of a second pMHC tetramer
ligand. a OT-1 T CD8+ T cells were preincubated at 0 °C with 1 nM OVAp-
APC tetramer for the indicated times and subsequently incubated with 5
nM of OVAp-PE tetramer for ﬁve additional minutes. Time 0 indicates
binding of OVAp-PE tetramer in the absence of preincubation with OVAp-
APC tetramer. Cells were ﬁxed and stained for CD8 before analysis by ﬂow
cytometry and calculation of the MFI for OVAp-PE and OVAp-APC.
Histograms for OVAp-APC tetramers and OVAp-PE tetramer ﬂuorescence
intensity are shown on the left panels. The MFI values for OVAp-APC
tetramers and OVAp-PE tetramer are represented on the right panels.
b CD8+ T cells from double transgenic female OT-1xHY mice were
preincubated on ice with 1 nM OVAp-APC tetramer for the indicated times
and subsequently incubated with 20 nM of HYp-PE tetramer for ﬁve
additional minutes. Cells were ﬁxed and stained for CD8 before analysis by
ﬂow cytometry to generate MFI values for HYp-PE and OVAp-APC
binding. All data shown in Fig. 3 represent the mean ± s.d. of triplicate
datasets; *p < 0.05; **p < 0.005; ****p < 0.00005 (2-tail unpaired t-test)
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High-resolution confocal microscopy imaging from previous
studies showing preferential recruitment of effector proteins and
phosphorylation of all TCRs in a restricted area of bigger
microclusters, instead of an even distribution, are suggestive of
cooperativity27, 28. We therefore looked at the distribution of
OVAp tetramer binding, compared with that of the TCR at the T-
cell–APC immunological synapse (IS). The location of a
CD3ζ–GFP fusion protein was used as indication of the total
TCR distribution. OT-1 T cells were preincubated for 8 min with
antigen-loaded DCs at 37 °C to allow the formation of an IS.
Subsequently, we examined the sites for preferential pMHC
binding in the IS by adding a soluble OVAp-APC tetramer for 5
min. We found that the OVAp tetramer bound only at the edges
of the T-cell–DC contact site, whereas the centre-accumulated
TCR that was not able to bind to OVAp tetramer (Fig. 7b). In
contrast, the sites for more intense OVAp tetramer binding
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highly co-localised with the TCR in its Active conformation, as
detected by APA1/1 staining, which was also present at the edges
of the IS. The centre of the IS was stained with a large (>1000
kDa) extracellular anti-CD3 antibody/streptavidin complex
(Supplementary Fig. 8), suggesting that poor binding of the
OVAp tetramer is not due to inaccessibility of the reagent to the
centre of the IS. Pearson correlation analysis of pixel distribution
in different T-cell–DC conjugates identiﬁed a much better co-
localisation of OVAp tetramer binding sites with APA1/1 than
with total TCR (Fig. 7b). These results suggest that TCRs in the
Active conformation are preferentially located at the periphery of
the IS and that, consequently, it is where enhanced binding of
soluble pMHC is detected.
Discussion
In this paper, we show the existence of homotropic allostery in
the TCR, i.e. the ﬁrst-binding events of pMHC ligand to TCRs
alter the binding properties of subsequent pMHC–TCR engage-
ments. This is demonstrated by using pMHC oligomers of dif-
ferent nature and colours at sub-saturating concentrations. These
ﬁrst-binding pMHCs favour binding of a second pMHC oligomer
to the vast majority of free TCRs still available. The cooperative
effect could also be demonstrated by using T cells bearing two
different TCR transgenes (OT-1 and HY) of unrelated pMHC
speciﬁcity. We demonstrated that cooperative binding is possible
because the TCR is organised in nanoclusters and our data
therefore suggest that the OT-1 and HY TCRs are intermingled in
the same nanoclusters. The positive cooperativity upon ligand
binding manifested in the ﬁrst 6–8 min after the initial binding
events can be explained by the adoption of the Active con-
formation by the entire TCR nanocluster including the unbound
TCRs at once. Consistent with the idea that Active conformation
is required for positive cooperativity, OT-1 T cells expressing the
C80G mutant of CD3ε did not show such cooperativity. We have
previously shown that the C80G mutation in the stalk domain of
CD3ε inhibits the outside-in transmission of conformational
changes. Moreover, expression of the C80G mutant in T cells that
express a large excess of endogenous wild-type CD3ε exerts a
dominant negative effect on T-cell activation29. This early evi-
dence of cooperativity was interpreted as a need for adoption of
Active conformation by the entire TCR nanocluster. The exis-
tence of inter-TCR cooperativity has also been suggested in view
of the non-random distribution of CD3ζ and ZAP70 phosphor-
ylation hotspots at preferential sites of TCR clusters27, 28. How-
ever, these last data could also be explained by trans-acting effects
of tyrosine kinases recruited to TCRs engaged by antigen. Our
experiments of inter-TCR cooperativity manifested on pMHC
ligand binding have been mostly carried out at 0 °C or in the
presence of the Src tyrosine kinase inhibitor PP2 to minimise the
participation of cytoplasmic effectors on the observed cooperative
effects. The effect of disrupting TCR nanoclusters with MβCD,
the correlation with optimum for APA1/1 binding, indicative of
the Active conformation, the optimum for cooperative pMHC
binding and the optimum for FRET intensity between TCRs all
point to a rearrangement of the TCR quaternary structure as the
basis for inter-TCR cooperativity. At present, we do not have
evidence for the intermolecular mechanisms that can result in the
transmission of the Active conformation from engaged to non-
engaged TCRs within a nanocluster. Nevertheless, the enhanced
FRET efﬁciency observed between two TCRβ or two TCRα
subunits after preincubation with a pMHC tetramer suggest that
movement of the αβ TCR ectodomains is ultimately the con-
sequence of lateral spreading of the Active conformation from
engaged to non-engaged TCRs. Indeed, enhanced binding of
monomeric pMHC promoted by preincubation with a pMHC
tetramer suggests that the pMHC-binding distal tips of the αβ
ectodomains move away from the plasma membrane pointing
towards the extracellular milieu as a way to facilitate pMHC
binding.
In an attempt to investigate if inter-TCR cooperativity upon
ligand binding is also manifested during antigen recognition in
physiological conditions, i.e. antigen presented by antigen-
presenting cells, we have also carried out ﬂow cytometry
experiments, in which we can detect a sharp temporal increase in
soluble pMHC binding when T cells are stimulated with antigen-
loaded DCs. This phenomenon was also corroborated by confocal
microscopy experiments. High-resolution microscopy would be
needed to pinpoint the locations at which the TCR is in the Active
conformation within the IS. Nonetheless, with the methods
employed here, we see a correlation between the TCR in the
Active conformation, detected with APA1/1, and the sites for
enhanced pMHC tetramer binding. We also show that the centre
of the IS is enriched in TCR, but not in enhanced pMHC binding.
A possible explanation for the poor staining of the IS centre is size
exclusion: a tight apposition of the DC and T-cell membranes at
the centre may preclude the diffusion of the pMHC tetramer
towards the centre. We show, however, that a large complex of
tetrameric anti-CD3 antibody is able to enter and stain the centre
of the IS. These data argue against a size-exclusion mechanism.
We rather propose that the centre of the IS is enriched in TCRs in
the Inhibited conformation. According to this model, TCR
allostery is manifested at the periphery of the IS, whereas at the
centre of the IS, the TCR presumably accumulates in its Inhibited
conformation. These data are in line with previous confocal
microscopy data showing that the TCR is associated at the per-
iphery of the IS with intracellular signalling proteins, whereas it is
Fig. 4 A multimeric pMHC ligand is required to promote cooperative pMHC binding. a CD8+OT-1 T cells were preincubated at 0 °C with 100 nM
biotinylated OVAp monomer for the indicated times and subsequently incubated with 5 nM of OVAp-APC tetramer for ﬁve additional minutes. Time 0
indicates binding of OVAp-APC tetramer in the absence of preincubation with OVAp monomer. Cells were ﬁxed and stained with streptavidin-PE in order
to detect binding of the monomer. Plots represent the MFI values for OVAp-PE monomer and OVAp-APC tetramer binding. b CD8+OT-1 T cells were
incubated at 0 °C with the indicated concentrations of biotinylated OVAp monomer for 6 min and subsequently incubated with 5 nM of OVAp-PE tetramer
for 5 additional minutes. Cells were then ﬁxed and stained with streptavidin-APC in order to detect the monomer. Plots represent the MFI values for
OVAp-APC monomer and OVAp-PE tetramer binding. c CD8+OT-1 T cells were preincubated at 0 °C with 1 nM OVAp-APC tetramer for the indicated
times and subsequently incubated with 1.5 μM of biotinylated OVAp monomer (detected with streptavidin-PE) for 5 additional minutes. Time 0 indicates
binding of OVAp monomer in the absence of preincubation with OVAp-APC tetramer. Cells were ﬁxed and stained with streptavidin-PE in order to detect
binding of the monomer. Plots represent the MFI values for OVAp-PE monomer and OVAp-APC tetramer binding. d CD8+OT-1 T cells were preincubated
or not at 0 °C with 1 nM of OVAp-PE tetramer for 6min prior to incubation with the indicated concentrations of biotinylated OVAp monomer for
ﬁve additional minutes. Cells were ﬁxed and stained with streptavidin-APC in order to detect binding of the monomer. Plots represent the MFI values
for OVAp-APC monomer and OVAp-PE tetramer binding. All data shown in Fig. 4 represent the mean ± s.d. of triplicate datasets; * p < 0.05; **p < 0.005;
***p < 0.0005 (2-tail unpaired t-test)
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essentially devoid of those effectors at the centre25, 30, 31. In fact, it
has been previously been proposed that the TCR accumulates at
the centre of the IS in a signalling-incompetent manner and from
there it is internalised and removed30, 32, 33. The signalling
incompetence of the TCR at the centre together with the large
concentration of TCR and MHC in that location could be
explained by our data that support the idea of TCR adopting
the Inhibited conformation at the centre. The translocation
time for engaged TCRs from the periphery to the centre of
the IS is roughly coincident with the time window for the
TCR to undertake the Resting to→Active to→Inhibited
transitions34, 35. At the periphery of the IS, the ﬁrst engagements
of the TCR favour engagement of subsequent ones in the same
nanocluster, resulting in signal ampliﬁcation. The requirements
for pMHC afﬁnity of the second set of engaged TCRs might be
lesser than those of the ﬁrst. Thus, signal ampliﬁcation may be
achieved during the secondary binding events by involving MHC
complexes loaded with low-afﬁnity ligands, such as self-
peptides19, 36. Adoption of the Inhibited conformation and loss
of cooperativity might be envisioned as a mechanism for T cells to
count the abundance of antigen because sustained signalling can
only be achieved through the recruitment of new TCRs from
other sites of the plasma membrane or from cytoplasmic traf-
ﬁcking vesicles.
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Methods
Mice. OT-1 mice express a transgenic TCR H-2Kb restricted and speciﬁc for
ovoalbumin peptide SIINFEKL (OVAp)37. The OT-1 CD3ζ-GFP transgenic mice
express a wild-type CD3ζ subunit fused with the green ﬂuorescent protein in a OT-
1 CD3ζ−/− background38. The OT-1 C80G knock-in mice express a CD3ε subunit
with a cysteine-to-glycine mutation in the stalk sequence of the ectodomain22. The
HY TCR is H-2Db restricted and speciﬁc for the male HY antigen39. T cells from
female HY TCR transgenic mice were used for all experiments involving this line.
All the mice were maintained under speciﬁc pathogen-free conditions at the animal
facility of the CBMSO in accordance with the current national and European
guidelines. All animal procedures were approved by the ethical committee of the
CSIC.
Cell preparation. Murine naïve OT-1 T cells were obtained from lymph nodes
from 6- to 8-week-old female mice by homogenisation and washing in phosphate
buffered saline (PBS) containing 10% (vol/vol) foetal bovine serum (FBS). T
lymphoblasts were obtained by homogenisation of the spleen, washing in PBS
containing 10% (vol/vol) FBS and stimulating splenic T cells with OVAp for two
days, then washing and expanding them with recombinant interleukin 2 (IL-2) for
another four days in RPMI medium [RPMI-10 supplemented with 0.01% sodium
pyruvate and 10 μM β-mercaptoethanol]40. For dendritic cell differentiation, bone
marrow precursors were obtained from femurs of 6–12-week-old C57BL/6 mice
and grown for 10–11 days of differentiation with GM-–CSF, as previously
described41.
pMHC tetramers and other reagents. Allophycocyanin (APC)-conjugated
OVAp/H-2Kb (SIINEFKL), phycoerythrin (PE)-conjugated OVAp/H-2Kb, unla-
belled OVAp/H-2Kb and PE-conjugated HY2p/H-2Db tetramers, and biotinylated
OVAp/H-2Kb monomers were obtained from TCMetrix. OVAp mutant for CD8
binding (OVAp CD8-blocked/H-2Kb, Q226D227K-OVAp) tetramer was produced
as previously described42. APC-conjugated OVAp/H-2Kb (SIINEFKL) and PE-
conjugated OVAp/H-2Kbdextramer were obtained from Immudex. The following
antibodies were obtained from BD Pharmingen and used at the following con-
centrations: ﬂuorescein isothiocyanate (FITC)-conjugated anti-CD8α (1:100),
peridinin chlorophyll protein complex (PerCP)-conjugated anti-CD3 (2C11)
(1:50), PE-conjugated anti-CD3 (2C11) (1:50, 1:25, 1:10), APC-conjugated anti-
CD3 (17A2) (1:10) and APC-conjugated anti CD27 (1:50). Brilliant Violet 421-
conjugated anti CD8α (1:100) was obtained from BioLegend. Antibody staining
was performed in PBS, 1% bovine serum albumin (BSA) and 0.02% sodium azide
during 30 min on ice. Methyl-beta cyclodextrin (MβCD) was obtained from Sigma-
Aldrich and used at a ﬁnal concentration of 10 mM to treat cells for 30 min in
RPMI medium at room temperature. PP2 was obtained from Calbiochem and used
at a ﬁnal concentration of 20 µM for 30 min at 37 °C.
Sequential binding of pMHC tetramers and APA1/1 staining. All the experi-
ments were performed in triplicates. For each condition, a total of 2 × 105 naïve
T cells or T lymphoblasts diluted in 30 µl of RPMI medium, buffered with 10 mM
Hepes, pH= 7.4, were stimulated with different concentrations of tetramers,
monomers or dextramers sequentially diluted in 10 µl of PBS, 1% BSA and 0.02%
sodium azide during different incubation times. Sodium azide was included
in all incubations on ice, but not at 37 °C to avoid metabolic side effects. When
we performed sequential incubations using two different tetramers or one
tetramer and a biotinylated monomer, tetramers were preincubated with an
excess of free biotin (1 mM) in order to block all possible free-biotin binding sites
from the streptavidin used for tetramerization and to prevent cross-labelling.
Tetramer binding was stopped by a fourfold dilution with ice-cold 2% paraf-
ormaldehyde (PFA), rapid spinning, washing with PBS, 1% BSA and 0.02% sodium
azide and further ﬁxation in 2% PFA for 20 min on ice. The ﬁxed cells were then
stained with antibodies against the appropriate extracellular markers or
streptavidin-APC for monomer detection and, where indicated, after permeabili-
zation with PBS, 1% BSA, 0.02% sodium azide and 0.01% saponin, cells were
stained with the APA1/1 monoclonal antibody (10 µg/ml). Alexa Fluor 488-
conjugated anti-mouse antibody was used to visualise APA1/1 staining22. For
experiments using a blocking anti-CD8 antibody, cells were incubated previously
with a saturating concentration of an anti-CD8-blocker (CT-CD8a Thermo Sci-
entiﬁc) for 40 min at 0 °C. For the cooperativity analysis using dendritic cells, bone
marrow dendritic cells (DCs) were differentiated during 10 days and loaded with
OVAp for 2–3 h before stimulation. Subsequently, a total of 1 × 105 OVAp-loaded
DCs were plated onto 96-well plates, and 2 × 105 naïve OT-1 T cells (ratio 1:2) were
added in a ﬁnal volume of 20 µl. The DC+ T-cell culture mixtures were incubated
for different times at 37 °C and, subsequently, cells were incubated with 5 nM of
APC-conjugated OVAp/H-2Kb tetramer for 5 min, and then ﬁxed and stained as
described above.
Confocal microscopy and immunoﬂuorescence. For each condition, a total of
1 × 105 bone-marrow-derived DCs were directly differentiated on glass coverslips
during 10 days, and loaded with OVAp for 2–3 h before T-cell stimulation. A total
of 2 × 105 puriﬁed lymph node CD8+ T cells from OT-1-CD3ζ-GFP mice were
added onto the DCs and incubated at 37 °C for different times. Subsequently, APC-
conjugated H-2kb tetramer at a ﬁnal concentration of 20 nM either alone or in
combination with a biotinylated anti-CD3ε (145-2C11) pre-conjugated with
streptavidin-Alexa 555 was added for 5 additional min, and they were then ﬁxed
and permeabilized as described previously43. Staining with the APA1/1 monoclonal
antibody was done after cell permeabilization, and Alexa Fluor 555-conjugated
anti-mouse was used as secondary antibody. Cells were examined on a Zeiss
Confocal LSM510 META microscope coupled to a vertical Axiovert200 microscopy
system with a 63 × Plan-Apochromat M27 oil immersion objective lens (1.4
numerical aperture). For quantiﬁcation, 16‐bit images were analysed using Fiji
software44. Brieﬂy, the intensity on the plasma membrane was quantiﬁed in cells at
the regions of interest (ROIs), and the MFI of each region was measured for each
channel. Where indicated, quantitative co‐localisation was carried out using the
Pearson Index intensity correlation analysis.
FRET analysis. For FRET analysis between TCR chains, a total of 2 × 105 OT-1 or
OT-1xHY lymph node naïve T cells were resuspended in complete RPMI medium
and incubated on ice with 1 nM of unlabelled H-2Kb-OVAp tetramer for different
times. Cells were ﬁxed with 2% PFA and subsequently stained at saturating con-
ditions for 30 min at 0 °C using different combinations of anti-TCR chains con-
jugated to APC (acceptor) or PE (donor) in PBS, 1% BSA and 0.02% sodium azide.
For FRET analysis between tetramers, a total of 200.000 OT-1 naïve T cells were
resuspended in complete RPMI medium and incubated on ice with 1 nM of PE-
conjugated H-2Kb-OVAp and 1 nM of APC-conjugated H-2Kb-OVAp tetramers
in the presence of free biotin for different times, and they were ﬁxed with 2% PFA.
The cells were analysed using a BD FACS Canto II equipped with violet (405 nm),
blue (488 nm) and red (633 nm) lasers. Using the blue laser line, PE and FRET
emissions were collected using 585/42 and LP670 ﬁlters, respectively, while after
delayed excitation with the red laser line, APC emission was collected using a 660/
20 ﬁlter. For each combination of antibodies, single controls for acceptor and
donor were included in order to correct their contribution to other channels. A
negative control using the acceptor and an anti-CD27-APC was also included for
all antibody combinations. Mean ﬂuorescence intensity (MFI) for each channel was
calculated for the double positive cells (PE+ APC+), or simple positive cells for the
controls, using FlowJo software. FRET efﬁciency was calculated using MFI for each
channel as previously described45.
Size-exclusion chromatography and fraction analysis. Sephacryl S-300 (GE-
Healthcare) was slurried and washed twice with Hepes buffered saline (HBS) and
subsequently degassed and packed in a 6-mL column 16/10. The column void
Fig. 5 Ligand binding cooperativity depends on TCR nanoclusters adopting the Active conformation. a OT-1 T cells were incubated with 10 mM
methyl-β-cyclodextrin (MβCD) or vehicle for 30min at 37 °C, cooled to 0 °C and preincubated with 1 nM OVAp-APC tetramer for the indicated times, then
incubated with 5 nM OVAp-PE for 5 additional min. Cells were ﬁxed and stained with the anti-TCRβ antibody H57 to assess TCR levels. Left panel: TCR
expression at each time point of preincubation with OVAp-APC for non-treated and MβCD-treated cells. Middle panel: OVAp-APC tetramer binding at
different times of preincubation. Right panel: OVAp-PE tetramer binding during 5min as a function of preincubation time with the OVAp-APC tetramer.
b Cartoon of a TCR indicating the position of the Cys80 residue mutated to glycine in the extracellular domain of CD3ε. c CD8+OT-1 T cells expressing
wild type or C80G mutant CD3ε were incubated at 0 °C with the indicated concentrations of OVAp-PE tetramer for 5 min. Cells were ﬁxed and stained
with the anti-CD3 antibody 2C11 to assess TCR expression (left panel). Tetramer binding data (right panel) was obtained from WT and CD3ε C80G cell
populations, and from a WT subpopulation gated for TCR expression similar to CD3ε C80G cells (WTnorm, left panel). d CD8+OT-1 T cells expressing
wild type or C80G CD3ε were preincubated at 0 °C with 1 nM OVAp-APC tetramer for the indicated times and with 5 nM OVAp-PE for 5 additional
minutes. Cells were ﬁxed and stained with the anti-TCRβ antibody H57 to normalise TCR levels. Left panel: OVAp-APC tetramer binding at different times
of preincubation. Right panel: OVAp-PE tetramer binding during 5min for all preincubation times in WT C80G OT-1 cells. OVAp-APC and OVAp-PE
tetramer binding is compared between CD3ε C80G mutant cells and CD3ε WT cells normalised for equal TCR expression as in c. All data shown in Fig. 5
represent the mean ± s.d. of triplicate datasets; *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.00005 (2-tail unpaired t-test)
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volume (Vo) was calculated from the elution volume for Blue Dextran 2000, and
calibration of the column was calculated from the elution volume of proteins with
known molecular weights. After calibration, a 60-μl sample of OVAp-PE tetramer
was loaded onto the column followed by elution with HBS. Fraction collection
started immediately after the column void volume had passed. The eluate was
collected in 96 sequential fractions of 75 µl. To evaluate the composition of each
fraction, 10 µl of each fraction was incubated for 40 min with 2 × 105 OT-1 CD8+
cells and analysed by ﬂow cytometry. In addition, 10 µl of each fraction was
FRET Sensitized
emission
MHC
Ag
MHC
Ag
MHC
Ag
MHC
Ag
MHC
Ag
MHC
Ag
MHC
Ag
MHC
Ag
PE APC
MHC-MHC FRET
0
50
100
150
200
0 2 4 6 8 10 12 14 16 18 20
F
R
E
T
 (
M
F
I)
Time (min)
0.0
0.1
0.2
0.3
0.4
0 2 4 6 8 10 12 14 16 18 20
F
R
E
T
 e
ffi
ci
en
cy
Time (min)
2 Tetramers
C–
C+
ba
Y
0.00
0.01
0.02
0.03
0 2 4 6 8 10
F
R
E
T
 e
ffi
ci
en
cy
Preincubation (min)
Vα2-Vβ5
C–
Vα2-Vβ5
C–
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0 2 4 6 8 10
F
R
E
T
 e
ffi
ci
en
cy
Preincubation (min)
w/o MbCD
Neg. Control w/o
MbCD
+MbCD
Neg. Control
+MbCD
Vβ5-Vβ5
C– w
/o
 M
βC
D
+
M
βC
D
O
T
1 
C
D
8+
 T
 c
el
ls
Vβ5-Vβ5
C–
Vα(OT1)-Vα(HY) FRET
O
T
1x
H
Y
 C
D
8+
 T
 c
el
ls
0.000
0.001
0.002
0.003
0.004
0.005
0.006
0 2 4 6 8 10
F
R
E
T
 e
ffi
ci
en
cy
Preincubation (min)
Vα2 T3.70
C–
Vα2-Vβ5 FRET
O
T
1 
C
D
8+
 T
 c
el
ls
w
/o
 M
βC
D
+
M
βC
D
ε ε ε ε
MHC
Ag Ag
Ag
MHC
PE
αα ββ
APC
Vβ5-Vβ5 FRET
* *
*
*
Anti-Vα2
Anti-Vβ5 Anti-Vβ5
Ag
MHC
MHC
dc
e f
Fig. 6 Ligand binding induces changes in the proximity or orientation of TCRs within nanoclusters. a Schematic of the experimental set-up of Fig. 6b. FRET
changes were detected upon simultaneous binding of PE- and APC-labelled OVAp tetramers. b CD8+OT-1 T cells were incubated on ice with 5 nM each
of OVAp-PE and OVAp-APC tetramers for the indicated times and ﬁxed. FRET intensity and efﬁciency (left and right panels) were measured by ﬂow
cytometry. For FRET controls, OT-1 T cells were incubated with 5 nM of the OVAp-PE tetramer for the indicated times and, after ﬁxation, cells were
further incubated for 50min with either APC-labelled anti-CD3 (positive control, C+ ) or APC-labelled anti-CD27 (negative control, C-) at saturating
concentrations. Arrows indicate the time points at which an upward tendency of the FRET slope was noticed. c Schematic of the experimental set-up in
d–f. FRET changes were detected in CD8+OT-1 T cells that bound PE-labelled OVAp tetramer and APC-labelled anti-Vβ5 antibody. d–f CD8+OT-1
or OT-1xHY T cells pretreated or not with 10mM MβCD for 30min at 37 °C and subsequently were incubated at 0 °C with 1 nM unlabelled OVAp
tetramer for the indicated times. After ﬁxation, they were incubated for 50min with anti-Vα2-PE and anti-Vβ5-APC (d), anti-Vβ5-PE and anti-Vβ5-APC
(e) or anti-T3.70-PE and Vα2-APC (f). For all antibody combinations, a negative control is included using the donor antibody and anti-CD27-APC (C-).
FRET efﬁciency is calculated as described in the Methods section and represented versus time of preincubation with tetramer. All data shown in Fig. 6
represent the mean ± s.d. of triplicate datasets; *p < 0.05 (2-tail unpaired t-test)
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05050-6
12 NATURE COMMUNICATIONS |  (2018) 9:2618 | DOI: 10.1038/s41467-018-05050-6 | www.nature.com/naturecommunications
+50
OVAp-loaded DCs FC
–10 –5–15Time (min):
5 
nM
 
OV
Ap
-P
E
37 °C
a
0
200
400
600
800
1000
1200
1400
0 5 10 15 20
Preincubation (min)
0
200
400
600
800
1000
1200
1400
0 5 10 15 20
Preincubation (min)
TCR expression
OVAp-PE binding
* ** * **
0
300
600
900
0 5 10 15 20
H
57
 a
nt
ib
od
y 
bi
nd
in
g 
(M
F
I)
O
V
A
p-
P
E
  b
in
di
ng
 (
M
F
I)
Preincubation (min)
Unloaded
OVAp-loaded
Vehicle +PP2
Merge CD3ζ APA1/1 OVAp-APCOverlay
DC
T cell
3500
3000
2000
1000
1500
2500
500
0
1400
1200
1000
800
600
400
200
CD3ζ
OVAp
tetramer
APA1/1
Distance (μm)
0 2 4 61 3 5 7
0
2.5
1.5
1.0
2.0
0.5 0.2
0.4
0.6
0.8
1.0
1.2
0
A
PA
1.
1/
C
D
3ζ
 r
at
io
Tetram
er/C
D
3ζ ratio
Distance (μm)
0 2 4 61 3 5 7
CD3ζ
0–
μm
–7
μm
1.0
–1.0
–0.5
0.5
0
P
ea
rs
on
 c
oe
ffi
ci
en
t
Tetramer vs. APA1/1
Tetramer vs. CD3ζ
APA1/1 vs. CD3ζ
******* 
n.s
****** 
O
V
A
p-
P
E
  b
in
di
ng
 (
M
F
I)
b
Fig. 7 The sites of enhanced tetramer binding co-localise with the Active TCR at the periphery of the immunological synapse. a CD8+OT-1 T cells were
treated with 20 µM PP2 or vehicle for 30min at 37 °C and then preincubated for the indicates times at 37 °C in the presence of mouse bone-marrow-
derived dendritic cells (mDCs) loaded with OVA peptide. Subsequently, cells were incubated with 5 nM OVAp-PE for 5 min. Afterwards, cells were ﬁxed
and stained with anti-CD8 and anti-H57 antibodies to quantify TCR expression. b CD8+ T cells from OT-1 CD3ζ-GFP mice were puriﬁed by negative
selection and incubated for 8min at 37 °C in the presence of mDCs attached to a coverslip and pre-loaded with OVA peptide. Subsequently, cells were
incubated with 20 nM OVAp-APC for 5 min. Before visualisation by confocal microscopy, cells were ﬁxed, permeabilized and stained with APA1-1 (top
panel). Scale bar represents 1 μm. Line scan drawn along the synaptic zone to show relative ﬂuorescence intensity of CD3ζ, APA1-1 and OVAp-tetramer
(middle left panel). Relative ﬂuorescence intensities of CD3ζ, APA1-1 and OVAp-tetramer are represented versus distance (middle centre). Ratios between
the relative ﬂuorescence intensity of APA1-1 and CD3ζ or OVAp-tetramer and CD3ζ are represented versus distance (middle right). Pearson correlation
coefﬁcients between the tetramer and APA1-1, the tetramer and CD3ζ, or APA1-1 and CD3ζ intensity distributions (bottom panel) are for n= 27
immunological synapses
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-05050-6 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:2618 | DOI: 10.1038/s41467-018-05050-6 |www.nature.com/naturecommunications 13
resolved by SDS–PAGE and western blotting with biotin-labelled horseradish
peroxidase.
Statistical analysis. Data are reported as means ± SD of multiple individual
experiments each carried out in triplicate. Unless stated otherwise, the statistical
analysis was carried out with GraphPad Prism 6.0. A two-tailed t-test was used if
two groups were compared. Differences were considered signiﬁcant if P values were
less than 0.05.
Data availability. The authors declare that the data supporting the ﬁndings of this
study are available within the paper and its Supplementary Information ﬁles, and
are available from the author upon request.
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